Pular para o conteúdo
Merck
Todas as fotos(1)

Key Documents

89170

Sigma-Aldrich

Thorium oxide

≥99.0%

Faça loginpara ver os preços organizacionais e de contrato


About This Item

Fórmula linear:
ThO2
Número CAS:
Peso molecular:
264.04
Número CE:
Número MDL:
Código UNSPSC:
12352300
ID de substância PubChem:

Ensaio

≥99.0%

adequação da reação

reagent type: catalyst
core: thorium

Extensão da rotulagem

7.15 kBq/g specific activity

cadeia de caracteres SMILES

O=[Th]=O

InChI

1S/2O.Th

chave InChI

ZCUFMDLYAMJYST-UHFFFAOYSA-N

Procurando produtos similares? Visita Guia de comparação de produtos

Advertência

Regulations require a license for the sale of radioactive substances in Switzerland. Swiss customers are kindly requested when ordering, to include their license number, issued by the Swiss Public Health Authorities.

Outras notas

Sales restrictions may apply
Regulations require a license for the sale of radioactive substances in Switzerland. Swiss customers are kindly requested when ordering, to include their license number, issued by the Swiss Public Health Authorities.

Pictogramas

Health hazardSkull and crossbones

Palavra indicadora

Danger

Frases de perigo

Declarações de precaução

Classificações de perigo

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Carc. 1B - STOT RE 2

Código de classe de armazenamento

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

Classe de risco de água (WGK)

WGK 3

Ponto de fulgor (°F)

Not applicable

Ponto de fulgor (°C)

Not applicable


Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

Não está vendo a versão correta?

Se precisar de uma versão específica, você pode procurar um certificado específico pelo número do lote ou da remessa.

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

[Carcinogenic chemicals and risk of hematopoietic neoplasms].
Masanobu Kobayashi
Nihon rinsho. Japanese journal of clinical medicine, 70 Suppl 2, 39-42 (2012-11-09)
Yoichiro Yamamoto et al.
Health physics, 99(3), 388-393 (2010-08-12)
Irradiation from internally deposited radionuclides induces malignant tumors. Ingested radionuclides accumulate in specific organs, which are irradiated over a lifelong period. Our aim is to elucidate why the development of malignant tumors requires long-term internal exposure, on the order of
Rakesh K Behera et al.
Journal of physics. Condensed matter : an Institute of Physics journal, 24(21), 215405-215405 (2012-05-12)
Thorium dioxide (ThO(2)) is of great interest to energy research as thorium-based nuclear fuel offers the promise of increased proliferation resistance, longer fuel cycles, higher burn-up and improved wasteform characteristics in the generation of nuclear power. However, understanding of ThO(2)
Yoichiro Yamamoto et al.
Cancer science, 101(2), 336-340 (2009-11-18)
Exposure to internally deposited radionuclides is known to induce malignant tumors of various histological types. Thorotrast, a colloidal suspension of radioactive Thorium dioxide ((232)ThO(2)) that emits alpha-particles, was used as a radiographic contrast during World War II. Thorotrast is known
G van Kaick et al.
Der Radiologe, 51(12), 1052-1057 (2011-11-18)
The medical management and counseling of persons at high risk due to exposure to chemicals or radiation or due to personal disposition, present an additional challenge for physicians and especially radiologists involved. This article is based on own experiences with

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica